Attovia Therapeutics prices upsized IPO at $17 per share
Attovia Therapeutics prices upsized IPO at $17 per share
Profit by knowlytics
Attovia Therapeutics prices upsized IPO at $17 per share
ASX 200 hits record high as miners rally, Iran hopes lift market sentiment
Attovia Therapeutics prices IPO at $17 per share on Nasdaq
Nikkei 225 nears 50% Fib resistance after 9% rally: Live levels
Nikkei 225 nears 200MA resistance at 67,140: Live levels
Dhoot Transmission has set the price band for its ₹3,067-crore IPO at ₹829–871 per share. The public issue will be open for subscription from August 10 to 12, with Axis Capital, Jefferies India, Kotak Mahindra Capital, Nomura Financial Advisory and Securities, SBI Capital Markets, and 360 ONE WAM serving as the book-running lead managers.
SK Hynix trapped at KRW 1,689,000 key level: Live levels
Asian stocks are set to track Wall Street higher as optimism grows. Prospects for an interim deal with Iran eased energy supply concerns significantly. This development has led to a slide in oil prices and reduced inflation pressures. Investors are now watching for further progress on reopening the Strait of Hormuz. This situation may strengthen…
Grace Therapeutics raises $10 million in private placement
Treasury yields declined on Tuesday as oil prices dropped significantly. This decrease followed reports of progress toward resolving the Iran conflict. Lower oil prices reduced inflation expectations and Fed rate hike forecasts. The two-year note yield reached its lowest point since late July. The benchmark ten-year yield settled at 4.62 percent.